Skip to main content

Table 4 Risk of composite adverse outcome among syphilis-seropositive pregnant women with different non-treponemal serum test titers by syphilis treatment status in Guangzhou, China, 2014–2016 a

From: Syphilis-attributable adverse pregnancy outcomes in China: a retrospective cohort analysis of 1187 pregnant women with different syphilis treatment

Treatment during pregnancy

Women with adverse outcomes, N (%)

Crude RR (95% CI)

Adjusted RR (95% CI)

Non-treponemal serum test titers ≤1:8 (N = 999)

 Treatment initiation

  Penicillin < 28w

95 (10.6)

reference

reference

  Penicillin ≥28w

25 (34.6)

0.88 (0.59–1.33)

0.91 (0.60–1.38)b

  No treatment

63 (41.7)

1.73 (1.31–2.28)

1.77 (1.31–2.40)b

 Treatment course

  2 courses

67 (14.9)

reference

reference

  1 course

31 (16.2)

1.09 (0.74–1.61)

1.21 (0.82–1.81)c

  Insufficient treatment

22 (16.9)

1.14 (0.73–1.77)

1.22 (0.78–1.91)c

  No treatment

63 (27.6)

1.86 (1.37–2.52)

Non-treponemal serum test titers >1:8 (N = 170)

 Treatment initiation

  Penicillin <28w

14 (15.9)

reference

reference

  Penicillin ≥28w

10 (43.5)

2.73 (1.40–5.34)

2.34 (1.22–4.48)b

  No treatment

34 (57.6)

3.62 (2.14–6.14)

2.93 (1.66–5.17)b

Treatment course

  2 courses

6 (14.7)

reference

reference

  1 course

7 (31.3)

3.39 (1.28–9.02)

2.19 (0.90–5.31)c

  Insufficient treatment

11 (50.0)

4.69 (1.95–11.32)

2.40 (1.05–5.52)c

  No treatment

34 (63.4)

6.15 (2.78–13.58)

  1. Abbreviations: RR relative risk, CI confidence intervals
  2. aNone-penicillin treatment cases were excluded
  3. bAdjusted for age, marital status, household registration, and multipara status
  4. cAdjusted for age, marital status, household registration, multipara status, and the start time of treatment in the gestation